Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Do Anti-ApoA-1 Antibodies Link Fatty Liver Disease and CVD?Anti-ApoA-1 antibodies appear to be common in patients with NAFLD and may drive both fat deposits and pro-inflammatory effects
in liver cells, although it remains to be seen whether they can be targeted.
Medscape Medical News, Jun 02, 2021
EAS Lipid Guidance: Start High-risk Patients on Combo DrugInstead of spending time starting very-high-risk patients unlikely to reach goal on a statin alone, clinicians should immediately
reach for combination statin-ezetimibe therapy, say European experts.
Medscape Medical News, Jun 29, 2021
Real-world PCSK9i Data in FH Reveal Conundrum of ReimbursementReal-world analysis shows evolocumab is as effective as in clinical trials of familial hypercholesterolemia, but high baseline
LDL and lack of statins underline issues of reimbursement for PCSK9is.
